These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


328 related items for PubMed ID: 22393089

  • 1. Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.
    Pritchard KI, Julian JA, Holloway CM, McCready D, Gulenchyn KY, George R, Hodgson N, Lovrics P, Perera F, Elavathil L, O'Malley FP, Down N, Bodurtha A, Shelley W, Levine MN.
    J Clin Oncol; 2012 Apr 20; 30(12):1274-9. PubMed ID: 22393089
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
    Fujii T, Yajima R, Tatsuki H, Kuwano H.
    Anticancer Res; 2016 Apr 20; 36(4):1785-9. PubMed ID: 27069160
    [Abstract] [Full Text] [Related]

  • 4. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.
    Veronesi U, De Cicco C, Galimberti VE, Fernandez JR, Rotmensz N, Viale G, Spano G, Luini A, Intra M, Veronesi P, Berrettini A, Paganelli G.
    Ann Oncol; 2007 Mar 20; 18(3):473-8. PubMed ID: 17164229
    [Abstract] [Full Text] [Related]

  • 5. FDG-PET for axillary lymph node staging in primary breast cancer.
    Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri E.
    Eur J Nucl Med Mol Imaging; 2004 Jun 20; 31 Suppl 1():S97-102. PubMed ID: 15133635
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer.
    Lovrics PJ, Chen V, Coates G, Cornacchi SD, Goldsmith CH, Law C, Levine MN, Sanders K, Tandan VR.
    Ann Surg Oncol; 2004 Sep 20; 11(9):846-53. PubMed ID: 15313737
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer.
    van der Hoeven JJ, Hoekstra OS, Comans EF, Pijpers R, Boom RP, van Geldere D, Meijer S, Lammertsma AA, Teule GJ.
    Ann Surg; 2002 Nov 20; 236(5):619-24. PubMed ID: 12409668
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients.
    Heusner TA, Kuemmel S, Hahn S, Koeninger A, Otterbach F, Hamami ME, Kimmig KR, Forsting M, Bockisch A, Antoch G, Stahl A.
    Eur J Nucl Med Mol Imaging; 2009 Oct 20; 36(10):1543-50. PubMed ID: 19415270
    [Abstract] [Full Text] [Related]

  • 14. The roles of 18F-FDG-PET/CT and US-guided FNAC in assessment of axillary nodal metastases in breast cancer patients.
    Nakano Y, Noguchi M, Yokoi-Noguchi M, Ohno Y, Morioka E, Kosaka T, Takahashi T, Minato H.
    Breast Cancer; 2017 Jan 20; 24(1):121-127. PubMed ID: 27015862
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. PET/CT in breast cancer staging is useful for evaluation of axillary lymph node and distant metastases.
    Davidson T, Shehade N, Nissan E, Sklair-Levy M, Ben-Haim S, Barshack I, Zippel D, Halevy A, Chikman B.
    Surg Oncol; 2021 Sep 20; 38():101567. PubMed ID: 33866190
    [Abstract] [Full Text] [Related]

  • 18. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.
    Ahn JH, Son EJ, Kim JA, Youk JH, Kim EK, Kwak JY, Ryu YH, Jeong J.
    Acta Radiol; 2010 Oct 20; 51(8):859-65. PubMed ID: 20670083
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.